DYRK2 and neoplasm: As such, in the present study we sought to conduct an in-depth analysis of the role of DYRK2 as a mediator of CRC cell chemoresistance, with a specific focus on its ability to regulate EMT induction through analyses of human tumor tissue samples, CRC cells, and animal model systems.